The project consists of only 1 reporting period. The goal of this period was to validate the business plan by market- and competative analysis. After a pre-market study we bought samples competitor´s products and quantified their level of antimicrobial agents and bioactivity in commercial labs.
Results of the Study:
The feasabilty study of FitFeed as a potentially new product of Microganic showed
• that the product concept of FitFeed and its superior level of ingredients has been validated,
• that the competing substances are actually cheaper available in the market than orginally assumed in the proposal,
• that the stronger effects and higher levels of bioactive ingredients do not justify a market price, which would be necessary for a profitable buisiness case.
The results therefore do not confirm the business plan of the proposal, which needs to be revised. Further action will need to be taken by Microganic before a market introduction of FitFeed can start. Microganic needs to find ways to further improve the value of the product or bring costs down. Alternatively FitFeed is not as competative in price, which would increase the risk of failure and make it difficult to justify high market introduction costs. An option to improve the value of the product is by prooving the superior antibacterial effects in a feeding trial, quantifying and prooving financial benefits for farmers. In this way customers can be convinced even to pay a higher price.
Before any decisions are taken, we will line-up further customer meetings and suggest higher prices for the product. We will get customer feedback again, but will also propose to introduce the product in premium niches first, e.g. in the “all natural segment” or the organic segment, which most large animal feed manufacturers have in their assortment. These premium segments can support higher priced ingredients, however, in the example of “organic” also Microganic´s cost prices will rise. Microganic will explore further options for marketing the product in an other way than originally envisaged.